Mauro Schechter

15.4k total citations · 3 hit papers
71 papers, 5.6k citations indexed

About

Mauro Schechter is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Mauro Schechter has authored 71 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Infectious Diseases, 46 papers in Virology and 19 papers in Emergency Medicine. Recurrent topics in Mauro Schechter's work include HIV/AIDS Research and Interventions (56 papers), HIV Research and Treatment (46 papers) and HIV/AIDS drug development and treatment (40 papers). Mauro Schechter is often cited by papers focused on HIV/AIDS Research and Interventions (56 papers), HIV Research and Treatment (46 papers) and HIV/AIDS drug development and treatment (40 papers). Mauro Schechter collaborates with scholars based in Brazil, United States and United Kingdom. Mauro Schechter's co-authors include Brian Gazzard, Patrick Yéni, José M. Gatell, David Katzenstein, Robert T. Schooley, Charles C. J. Carpenter, Melanie Thompson, Martin Hirsch, Douglas D. Richman and Donna M. Jacobsen and has published in prestigious journals such as The Lancet, JAMA and PLoS ONE.

In The Last Decade

Mauro Schechter

68 papers receiving 5.4k citations

Hit Papers

Treatment for Adult HIV Infection 2002 2026 2010 2018 2006 2004 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment for Adult HIV Infection
    2006 767 citations Mauro Schechter, José M. Gatell et al. profile →
  2. Treatment for Adult HIV Infection
    2004 601 citations Mauro Schechter, José M. Gatell et al. profile →
  3. Antiretroviral Treatment for Adult HIV Infection in 2002
    2002 573 citations David A. Cooper, José M. Gatell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mauro Schechter Brazil 34 4.6k 3.3k 1.6k 1.3k 322 71 5.6k
Kholoud Porter United Kingdom 39 3.5k 0.8× 2.5k 0.8× 1.8k 1.1× 1.0k 0.8× 306 1.0× 138 4.6k
Diane Aschman United States 7 5.7k 1.2× 3.8k 1.2× 2.9k 1.8× 2.0k 1.5× 320 1.0× 12 7.8k
François Raffi France 40 5.1k 1.1× 3.6k 1.1× 1.4k 0.9× 1.4k 1.1× 258 0.8× 208 6.3k
Andrew Zolopa United States 43 5.6k 1.2× 3.6k 1.1× 1.9k 1.2× 1.3k 1.0× 657 2.0× 107 6.9k
Markus Flepp Switzerland 33 4.1k 0.9× 2.8k 0.8× 2.0k 1.3× 1.0k 0.8× 286 0.9× 74 5.6k
Judith Feinberg United States 43 5.0k 1.1× 3.3k 1.0× 3.2k 2.0× 1.2k 0.9× 351 1.1× 169 8.0k
Benita Yip Canada 43 6.0k 1.3× 3.4k 1.0× 2.5k 1.6× 1.3k 1.0× 658 2.0× 110 6.6k
Richard Marlink United States 37 4.2k 0.9× 3.6k 1.1× 1.7k 1.1× 732 0.6× 565 1.8× 128 6.0k
Keith Henry United States 49 4.4k 1.0× 3.9k 1.2× 1.9k 1.2× 1.4k 1.1× 274 0.9× 135 7.2k
Cissy Kityo Uganda 38 4.5k 1.0× 2.8k 0.9× 1.6k 1.0× 735 0.6× 621 1.9× 202 5.6k

Countries citing papers authored by Mauro Schechter

Since Specialization
Citations

This map shows the geographic impact of Mauro Schechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Schechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Schechter more than expected).

Fields of papers citing papers by Mauro Schechter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauro Schechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Schechter. The network helps show where Mauro Schechter may publish in the future.

Co-authorship network of co-authors of Mauro Schechter

This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Schechter. A scholar is included among the top collaborators of Mauro Schechter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauro Schechter. Mauro Schechter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schechter, Mauro. (2016). Profilaxia pré e pós-exposição: o uso de drogas antirretrovirais para a prevenção da transmissão sexual da infecção pelo HIV. The Brazilian Journal of Infectious Diseases. 2(4). 112–117. 2 indexed citations
2.
Nachega, Jean B., Olatunji Adetokunboh, Olalekan A. Uthman, et al.. (2016). Community-Based Interventions to Improve and Sustain Antiretroviral Therapy Adherence, Retention in HIV Care and Clinical Outcomes in Low- and Middle-Income Countries for Achieving the UNAIDS 90-90-90 Targets. Current HIV/AIDS Reports. 13(5). 241–255. 94 indexed citations
3.
Mulligan, Kathleen, David V. Glidden, Peter L. Anderson, et al.. (2015). Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases. 61(4). 572–580. 113 indexed citations
4.
Schechter, Mauro, et al.. (2015). Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals. PLoS Computational Biology. 11(12). e1004665–e1004665. 56 indexed citations
5.
Thornhill, John, Jamie Inshaw, Pontiano Kaleebu, et al.. (2014). Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection. Journal of the International AIDS Society. 17(4S3). 19480–19480. 37 indexed citations
6.
Hamlyn, Elizabeth, Sarah Fidler, Wolfgang Stöhr, et al.. (2013). Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression. AIDS. 28(6). 869–874. 22 indexed citations
7.
Calmy, Alexandra, Éric Balestre, Fabrice Bonnet, et al.. (2012). Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings. BMC Infectious Diseases. 12(1). 147–147. 8 indexed citations
8.
Pulido, Federico, Mauro Schechter, Eugènia Negredo, et al.. (2011). Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis. PLoS ONE. 6(7). e22003–e22003. 71 indexed citations
9.
Altice, Frederick L., Adeeba Kamarulzaman, Vincent Soriano, Mauro Schechter, & Gerald Friedland. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet. 376(9738). 367–387. 407 indexed citations
10.
Nunes, Estêvão Portela, Marília Santini de Oliveira, Roberto Zajdenverg, et al.. (2009). Monotherapy with Lopinavir/Ritonavir as Maintenance After HIV-1 Viral Suppression: Results of a 96-Week Randomized, Controlled, Open-Label, Pilot Trial (KalMo Study). HIV Clinical Trials. 10(6). 368–374. 39 indexed citations
11.
Nash, Denis, Monica Katyal, Martin W. G. Brinkhof, et al.. (2008). Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS. 22(17). 2291–2302. 152 indexed citations
12.
Moyle, Graeme, José M. Gatell, Carlo Federico Perno, et al.. (2008). Potential for New Antiretrovirals to Address Unmet Needs in the Management of HIV-1 Infection. AIDS Patient Care and STDs. 22(6). 459–471. 22 indexed citations
13.
Langenberg, Patricia, Laura L. Hungerford, Marc Boulay, et al.. (2008). The Use of Supplementary Techniques to Increase Recall of Sex Partners in a Network-Based Research Study in Rio de Janeiro, Brazil. Sexually Transmitted Diseases. 35(7). 674–678. 6 indexed citations
14.
Cleghorn, Farley, Jean W. Pape, Mauro Schechter, et al.. (2007). Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(2). 222–230. 25 indexed citations
15.
Djomand, Gaston, Ann Duerr, José Cláudio Faulhaber, et al.. (2006). Viral Load and CD4 Count Dynamics After HIV-1 Seroconversion in Homosexual and Bisexual Men in Rio de Janeiro, Brazil. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(4). 401–404. 12 indexed citations
16.
Hofer, Cristina Barroso, Mauro Schechter, & Lee H. Harrison. (2004). Effectiveness of Antiretroviral Therapy Among Patients Who Attend Public HIV Clinics in Rio de Janeiro, Brazil. JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(4). 967–971. 32 indexed citations
17.
Harrison, Lee H. & Mauro Schechter. (1998). Coinfection with HTLV-I and HIV: Increase in HTLV-I—Related Outcomes but Not Accelerated HIV Disease Progression?. AIDS Patient Care and STDs. 12(8). 619–623. 14 indexed citations
18.
Schechter, Mauro, Lawrence H. Moulton, & Lee H. Harrison. (1997). HIV Viral Load and CD4+ Lymphocyte Counts in Subjects Coinfected With HTLV-I and HIV-1. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(4). 308–311. 33 indexed citations
19.
Nucci, Márcio, et al.. (1995). Antibiotic regimen as an independent risk factor for disseminated fungal infections in neutropenic patients in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene. 89(1). 107–110. 8 indexed citations
20.
Puccioni‐Sohler, Marzia, et al.. (1991). Aids e miopatia relato de um caso e revisão da literatura. Arquivos de Neuro-Psiquiatria. 49(3). 352–356.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kholoud Porter Breakdown of academic impact, for papers by Diane Aschman Breakdown of academic impact, for papers by François Raffi Breakdown of academic impact, for papers by Andrew Zolopa Breakdown of academic impact, for papers by Markus Flepp Breakdown of academic impact, for papers by Judith Feinberg Breakdown of academic impact, for papers by Benita Yip Breakdown of academic impact, for papers by Richard Marlink Breakdown of academic impact, for papers by Keith Henry Breakdown of academic impact, for papers by Cissy Kityo
Rankless by CCL
2026